PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.45%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.94B
AUM Growth
+$3.94B
(+8.7%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
2.61%
Top 10 Holdings %
Top 10 Hldgs %
35.69%
Holding
116
New
34
Increased
29
Reduced
19
Closed
32
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$99.4M |
| 2 |
HCA Healthcare
HCA
|
$98.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
$87.1M |
| 4 |
Elevance Health
ELV
|
$84.3M |
| 5 |
VMW
VMware, Inc
VMW
|
$72.2M |
Top Sells
| 1 |
Bausch Health
BHC
|
$101M |
| 2 |
McKesson
MCK
|
$82.1M |
| 3 |
Stryker
SYK
|
$66.2M |
| 4 |
Pfizer
PFE
|
$66M |
| 5 |
Gilead Sciences
GILD
|
$63.5M |
Sector Composition
| 1 | Healthcare | 47.71% |
| 2 | Technology | 10.44% |
| 3 | Communication Services | 8.16% |
| 4 | Industrials | 7.02% |
| 5 | Financials | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Karyopharm Therapeutics
KPTI
$61.4M
| $22.4M | 0.57% |
821,594
-302,462
| -27% | -$8.23M |
|
52
Delta Air Lines
DAL
$40B
| $22.1M | 0.56% |
538,650
+36,607
| +7% | +$1.5M |
|
53
Ally Financial
ALLY
$12.6B
| $21.8M | 0.55% |
+970,811
| New | +$21.8M |
|
|
BLUE
54
DELISTED
bluebird bio
BLUE
| $21.4M | 0.54% |
127,170
-72,575
| -36% | -$12.2M |
|
|
BPMC
55
DELISTED
Blueprint Medicines
BPMC
| $20.9M | 0.53% |
+862,165
| New | +$20.9M |
|
56
Netflix
NFLX
$521B
| $20M | 0.51% |
30,482
-4,834
| -14% | -$3.18M |
|
57
Bruker
BRKR
$4.45B
| $19.9M | 0.5% |
972,911
+330,598
| +51% | +$6.75M |
|
|
SIOX
58
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $19.4M | 0.49% |
+952,745
| New | +$19.4M |
|
|
KITE
59
DELISTED
Kite Pharma, Inc.
KITE
| $18.8M | 0.48% |
309,152
+133,158
| +76% | +$8.12M |
|
60
Acadia Healthcare
ACHC
$2.15B
| $17.8M | 0.45% |
+227,174
| New | +$17.8M |
|
|
ADAP
61
Adaptimmune Therapeutics
ADAP
$13.9M
| $17.7M | 0.45% |
+965,515
| New | +$17.7M |
|
62
Herbalife
HLF
$1.02B
| $15.6M | 0.4% |
+283,825
| New | +$15.6M |
|
63
Anywhere Real Estate
HOUS
$670M
| $14.9M | 0.38% |
+318,018
| New | +$14.9M |
|
64
Community Health Systems
CYH
$392M
| $13.5M | 0.34% |
+214,664
| New | +$13.5M |
|
65
Molina Healthcare
MOH
$9.6B
| $11.8M | 0.3% |
167,234
-137,300
| -45% | -$9.65M |
|
|
66
Pfizer
PFE
$141B
| $10.6M | 0.27% |
314,670
-1,968,203
| -86% | -$66M |
|
|
ATML
67
DELISTED
ATMEL CORP
ATML
| $10.1M | 0.26% |
+1,025,467
| New | +$10.1M |
|
68
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $8.33M | 0.21% |
+288,079
| New | +$8.33M |
|
|
PGND
69
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $6.7M | 0.17% |
+233,662
| New | +$6.7M |
|
70
LendingClub
LC
$1.88B
| $6.42M | 0.16% |
+435,202
| New | +$6.42M |
|
|
JUNO
71
DELISTED
Juno Therapeutics, Inc.
JUNO
| $6.34M | 0.16% |
118,954
-395,631
| -77% | -$21.1M |
|
72
PTC Therapeutics
PTCT
$4.41B
| $5.6M | 0.14% |
116,268
+64,939
| +127% | +$3.13M |
|
|
ONCE
73
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $4.65M | 0.12% |
+77,141
| New | +$4.65M |
|
|
FOMX
74
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.58M | 0.12% |
+446,909
| New | +$4.58M |
|
75
Silicon Laboratories
SLAB
$4.3B
| $3.44M | 0.09% |
+63,709
| New | +$3.44M |
|